+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mitsubishi Tanabe Pharma Corporation - logo

Mitsubishi Tanabe Pharma manufactures pharmaceuticals, primarily ethical drugs in Japan. It focuses on the fields of circulatory system and metabolism, neuropsychiatry, the respiratory system and immunology, and oncology and hepatology. It sells products such as anticoagulant Anplag, anti-allergy medicine Talion, liver drug Urso, and neuroprotective agent Radicut. The company was founded in 1901 and is headquartered in Osaka, Japan.

From
Leukotriene Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multiple Sclerosis Drugs Market Report 2025 - Product Thumbnail Image

Multiple Sclerosis Drugs Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
GLP-1 Receptor Agonist Market Report 2025 - Product Thumbnail Image

GLP-1 Receptor Agonist Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Sensory Neuropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Sensory Neuropathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Porphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Porphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
From
From
5-HT1A Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1A Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chagas Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chagas Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
DPP-IV Inhibitors - Global Strategic Business Report - Product Thumbnail Image

DPP-IV Inhibitors - Global Strategic Business Report

  • Report
  • June 2025
  • 262 Pages
  • Global
From
From
Diabetic Kidney Diseases - Global Strategic Business Report - Product Thumbnail Image

Diabetic Kidney Diseases - Global Strategic Business Report

  • Report
  • June 2025
  • 372 Pages
  • Global
From
From
From
SGLT2 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

SGLT2 Inhibitors - Global Strategic Business Report

  • Report
  • June 2025
  • 69 Pages
  • Global
From
Anti-infective Vaccines Market Report 2023-2033 - Product Thumbnail Image

Anti-infective Vaccines Market Report 2023-2033

  • Report
  • September 2023
  • 303 Pages
  • Global
From
Loading Indicator